付録

Bulletin Board: Volume 5 Issue 2

• 抽象的な

付録

Author guidelines: Volume 5 Issue 2

• 抽象的な

付録

Acknowledgment: Volume 5 Issue 2

• 抽象的な

付録

Indices: Volume 5 Issue 2

• 抽象的な

付録

Glossary: Volume 5 Issue 2

• 抽象的な

総説

Vascular parkinsonism

Kurt A Jellinger

• 抽象的な

総説

Pharmacotherapy of obesity

Kostas Lois and Sudhesh Kumar

• 抽象的な

総説

Indirect and direct anticoagulants predominantly inhibiting factor Xa

Job Harenberg

• 抽象的な

総説

Venous thromboembolism: racial and ethnic influences

Raj K Patel and Roopen Arya

• 抽象的な

総説

Long-term outcome of pulmonary embolism

Guy Meyer, Benjamin Planquette and Olivier Sanchez

• 抽象的な

視点

Are isolated distal deep-vein thromboses clinically significant?

AT Cohen, S Balaratnam and N Fassiadis

• 抽象的な

会議風景

Updates on thrombosis treatment

R Hoffman

• 抽象的な

総説

Association of hyperhomocysteinemia with osteoporosis: a systematic review

Pooneh Salari, Bagher Larijani and Mohammad Abdollahi

• 抽象的な

医薬品の評価

Rasagiline for the management of Parkinson’s disease

Khashayar Dashtipour, Jack J Chen and Mark F Lew

• 抽象的な

社説

Occupational therapy after stroke: a right not a privilege?

Avril Drummond and Lynn Legg

• 抽象的な

インタビュー

Dr Anna Falanga speaks to Charlotte Barker, Commissioning Editor

Anna Falanga

• 抽象的な

社説

Where does patient self-management of oral anticoagulation fit within the current models of service provision?

D A Fitzmaurice

• 抽象的な

社説

Warfarin pharmacogenetics: up close and personalized

John F Carlquist and Jeffrey L Anderson

• 抽象的な